FDA Clears ION Stent From Boston Scientific The latest generation of drug-eluti

FDA Clears ION Stent From Boston Scientific

The latest generation of drug-eluting stent from Boston Scientific Corp. has been given the nod by the U.S. Food and Drug Administration (FDA). The ION Paclitaxel-eluting platinum chromium coronary stent system is the company’s third-generation drug-eluting stent technology.